Retorlix SP

Yes, the use of Retorlix SP 50mg/5mg Tablet can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better. Do not drive or use any machines.

Yes, Retorlix SP 50mg/5mg Tablet can cause gout. Retorlix SP 50mg/5mg Tablet contains torasemide which can increase the blood uric acid levels by increasing its absorption from the kidneys. Increased uric acid levels can cause a gout attack. Inform your doctor if you have hyperuricemia (excess of uric acid in blood) or a history of gout before taking this medicine. Use of Retorlix SP 50mg/5mg Tablet should be avoided in patients with gout.

Yes, the use of Retorlix SP 50mg/5mg Tablet can cause dehydration (excessive loss of fluid). The patient may experience dryness of the mouth, thirst, drowsiness, restlessness, muscle pain, weakness, tiredness, fall in blood pressure (hypotension), decreased urination (oliguria), increased heart rate (tachycardia), nausea and vomiting. Inform your doctor if you experience persistent problems while taking this medicine.

Yes, Retorlix SP 50mg/5mg Tablet can cause hyperkalemia (increased potassium levels). This occurs more commonly in patients with underlying kidney disease or in patients taking excessive potassium in their diet. High potassium levels can cause fatal heart problems. It is very important to get electrolytes and kidney function tests done on a regular basis while you are taking this medicine.

The use of Retorlix SP 50mg/5mg Tablet should be avoided in patients with hypersensitivity to torasemide, sulfonylureas or spironolactone or any other ingredient of the product. The use of this medicine should also be avoided in patients with anuria, acute renal insufficiency, hepatic coma and pre-coma, low blood pressure (hypotension), cardiac arrhythmias, patients taking aminoglycosides or cephalosporins, kidney dysfunction due to drugs which cause renal damage, patients with high potassium levels (hyperkalemia), Addison's disease and in children with moderate to severe renal impairment.

Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

Retorlix SP 50mg/5mg Tablet is a fixed-dose combination of torasemide (a loop diuretic) and spironolactone (an antagonist of aldosterone). Both are diuretics and they help to remove excess fluid from the body. The use of this combination is advised in patients of congestive heart failure (heart failure leading to fluid accumulation in the lung and rest of the body), nephrotic syndrome (a kidney disorder), liver cirrhosis with fluid retention (edema) and swelling of the abdomen (ascites).

Yes, Retorlix SP 50mg/5mg Tablet is safe to use in most of the patients. However, in some patients it may cause common side effects like dizziness, dehydration, decreased sodium level in blood, breast enlargement in males, decreased magnesium level in blood, decreased calcium level in blood, increased blood uric acid. Inform your doctor if you experience any persistent problem while taking this medicine.